Here, we focussed on a molecularly defined group of patients with PML-RARA+ tAPL and present evidence that in these patients, in contrast to de novo APL, chromosome translocations may be secondary events, arising on a background of pre-existing CH. This evidence concerns the gene RARA and cyclic hematopoiesis.